Olympus Wins a 2021 Edison Award for Automated Cell Culture System

Winners are chosen by fellow trailblazers and inventors around the world

WALTHAM, Mass., (June 24, 2021)—Olympus is proud to announce its OLYMPUS Provi™ CM20 incubation monitoring system won a Bronze Edison Award in the Cellular Research and Disease Prevention category for its innovative design that automates the cell culture workflow. Named after prolific inventor Thomas A. Edison, an Edison Award is one of the most prestigious accolades honoring excellence in new product development, design and innovation.

Automated Cell Culture Workflow
The traditional cell culture workflow requires users to check cell conditions—including cell morphology, confluency and count—by removing samples from the incubator and observing them under a microscope every two to three days. This time-consuming, qualitative process leads to increased workloads, higher costs and cell quality results that vary depending on the user.

The CM20 monitor offers a more accurate, cost-effective and streamlined cell culture workflow by providing quantitative data remotely. Just place the head and cell cultures in the incubator, and the system will periodically scan it to count cells and determine confluency. Data is wirelessly communicated to a PC or tablet, so users can monitor cultures without entering the cleanroom and acquire consistent results throughout the lab.

The Future of Cell Culture
Cell culture is growing in importance with the advancement of cell therapy through gene editing technology and stem cell studies. The award-winning CM20 monitor contributes to a stable and quantitative cell culture process to support emerging research and science.

“We are honored to be recognized for the breakthrough technology of the CM20 incubation monitoring system and the value it brings to the cell culture market,” said Lee Wagstaff, Vice President of Life Science Sales and Marketing at Olympus Corporation of the Americas. “I look forward to seeing its impact on cell culture as the industry enters a new era of innovation, scientific discoveries and productivity.”

For more information about the CM20 incubation monitoring system, visit www.Olympus-LifeScience.com/Cell_Culture_Solution/CM20. To learn more about the Edison Awards and past winners, visit www.EdisonAwards.com.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2021, June 25). Olympus Wins a 2021 Edison Award for Automated Cell Culture System. News-Medical. Retrieved on July 13, 2024 from https://www.news-medical.net/news/20210625/Olympus-Wins-a-2021-Edison-Award-for-Automated-Cell-Culture-System.aspx.

  • MLA

    Evident Corporation - Life Sciences. "Olympus Wins a 2021 Edison Award for Automated Cell Culture System". News-Medical. 13 July 2024. <https://www.news-medical.net/news/20210625/Olympus-Wins-a-2021-Edison-Award-for-Automated-Cell-Culture-System.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "Olympus Wins a 2021 Edison Award for Automated Cell Culture System". News-Medical. https://www.news-medical.net/news/20210625/Olympus-Wins-a-2021-Edison-Award-for-Automated-Cell-Culture-System.aspx. (accessed July 13, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2021. Olympus Wins a 2021 Edison Award for Automated Cell Culture System. News-Medical, viewed 13 July 2024, https://www.news-medical.net/news/20210625/Olympus-Wins-a-2021-Edison-Award-for-Automated-Cell-Culture-System.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-based pathology diagnosis tool in development detects 7 types of gastric cancer